title: First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006).
abstract: The present document contains recommendations for assessment, prevention and treatment of cardiovascular risk for HIV-infected patients. All recommendations were graded according to the strength and quality of the evidence and were voted on by 73 members of the Italian Cardiovascular Risk Guidelines Working Group which includes both experts in HIV/AIDS care and in cardiovascular and metabolic medicine. Since antiretroviral drug exposure represents only one risk factor, continued emphasis on an integrated management is given. This should include prevention and treatment of known cardiovascular risk factors (such as dyslipidaemia, diabetes, insulin resistance, healthy diet, physical activity, avoidance of smoking), but also rational switch of antiretroviral drugs. A rational switch strategy should consider both metabolic and anthropometric disturbances and effectiveness of antiretroviral regimens.
authors.affiliation: Clinica di Malattie Infettive e Tropicali, Università degli Studi di Brescia, P.le Spedali Civili, 1, 25123, Brescia, Italy. torti.carlo@libero.it
authors.forename: G
authors.initials: G
authors.lastname: Carosi
authors.forename: E
authors.initials: E
authors.lastname: Quiros-Roldan
authors.forename: C
authors.initials: C
authors.lastname: Torti
authors.forename: A
authors.initials: A
authors.lastname: Antinori
authors.forename: M
authors.initials: M
authors.lastname: Bevilacqua
authors.forename: R C
authors.initials: RC
authors.lastname: Bonadonna
authors.forename: P
authors.initials: P
authors.lastname: Bonfanti
authors.forename: A
authors.initials: A
authors.lastname: Castagna
authors.forename: R
authors.initials: R
authors.lastname: Cauda
authors.forename: A
authors.initials: A
authors.lastname: d'Arminio-Monforte
authors.forename: P
authors.initials: P
authors.lastname: Di Gregorio
authors.forename: G
authors.initials: G
authors.lastname: Di Perri
authors.forename: R
authors.initials: R
authors.lastname: Esposito
authors.forename: F
authors.initials: F
authors.lastname: Fatuzzo
authors.forename: C
authors.initials: C
authors.lastname: Gervasoni
authors.forename: C
authors.initials: C
authors.lastname: Giannattasio
authors.forename: G
authors.initials: G
authors.lastname: Guaraldi
authors.forename: A
authors.initials: A
authors.lastname: Lazzarin
authors.forename: S
authors.initials: S
authors.lastname: Lo Caputo
authors.forename: P
authors.initials: P
authors.lastname: Maggi
authors.forename: F
authors.initials: F
authors.lastname: Mazzotta
authors.forename: M
authors.initials: M
authors.lastname: Moroni
authors.forename: T
authors.initials: T
authors.lastname: Prestileo
authors.forename: R
authors.initials: R
authors.lastname: Ranieri
authors.forename: G
authors.initials: G
authors.lastname: Rizzardini
authors.forename: R
authors.initials: R
authors.lastname: Russo
authors.forename: M
authors.initials: M
authors.lastname: Galli
mesh_terms: D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D015415:Biomarkers; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D048909:Diabetes Complications; D004347:Drug Interactions; D050171:Dyslipidemias / Q000150:complications; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007333:Insulin Resistance; D007558:Italy; D008297:Male; D012307:Risk Factors
chemical_list: D015415:Biomarkers